Edguider Online Blog on ED, viagra, cialis and levitra

What the future holds for Erectile Dysfunction medications:

We all know the current treatment options men have when it comes to erectile dysfunction. Need I say their names? The PDE-5 inhibitors Viagra, Cialis and Levitra have become blockbuster medications that have been proven to be very effective for men who cannot get an erection on their own. But are they the only options? For now, yes, what you don’t know is what is yet to come.

Various pharmaceutical companies across the globe are struggling to get their products on the market. What is taking so long? Health officials, trials, testing, phases 123 and approvals are all part of the process that goes into getting these new products on the market. It can take pharmaceutical companies years before they break into the ED market which is worth billions.

See a complete list of Erectile Dysfunction treatment options

Out of many that are probably being testing as we speak, there are about 4 new erectile dysfunction medications that have made it through several clinical trials and many of them are in the final stages of being approved. Once they get the OK and hit pharmacies, it will bring a huge shift to the current market leaders and the ED market in general. It is an extremely competitive field.

Viagra will loose its patent in 2012 and generic versions will become widely available, take a look at the forecast of what will happen then:

Erectile Dysfunction Pipeline Assessment and Market Forecasts to 2017

What products are in the ED pipeline?

1) Avanafil: Being developed by Vivus, this is the one that is showing the most potential and is almost ready to hit the market. Studies that have already been conducted, reveled Avanfil can work in as little as 15 minutes. It has already completed its stage three trials, which is one of the final tests.

Avanafil Meets Goals and Works In As Little As 15 Minutes

Some researcher’s say it is being released a little late due to the Viagra patent expiration:

Business wire quote:

“One of the promising molecules is Avanafil, which is unlikely to have much impact as the market has high competition among similar products and will experience generic erosion after 2012 due to patent expiry of Viagra”

2) Zoraxel: This medication is also making some big noise. Being developed by Rexahn Pharmaceuticals, Zoraxel was proven to be very safe with limited side effects. It completed what is called phase 2b trials, just a few foot steps behind Avanafil.

Rexahn confirmed with one of our readers in the Edguider forum, (go to post Zoraxel in 2013) that Zoraxel works on areas in the brain that relate to arousal, erection and release, which is something that can really tackle performance anxiety. It should be ready by 2013 but will have a tough time breaking into the market with generic versions of Viagra already available. You can keep up with the latest news on Zoraxel in our forum, there is a thread dedicated to this up comer:

 Latest news on ZORAXEL! – EDGuider Forum

3) Zydena: Made by a Korean Pharmaceutical manufacturer, this medication has actually already been approved in several countries. Russia and Malaysia are two of them, who are already selling Zydena. We recently reported on the release of Zydena in Malaysia, you can read the article here:

“The Malaysian health ministry has approved a new prescription medication that primarily addresses the widespread problem of premature ejaculation and ED. Zydena also called Udenafil for its active ingredient, is now available” read more…

Although Russian and Malaysian men have access to Zydena, countries such as the US, Europe and Canada might be in for a longer wait. Approval processes in these countries go through phases and are much more detailed and complex.

This covers the top three, stay tuned for more. There are several others that are sizzling and being discussed in our forum, such as Bremelanotide and even gene therapy for ED. You can read up on it in the Edguider Forum or post your thoughts by registering.